As filed with the Securities and Exchange Commission on August 5, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMARIN CORPORATION PLC
(Exact name of registrant as specified in its charter)
| England and Wales | Not Applicable | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
77 Sir John Rogerson’s Quay, Block C
Grand Canal Docklands
Dublin 2, Ireland
+353 1 6699 020
(Address of Principal Executive Offices)
Amarin Corporation plc 2020 Stock Incentive Plan
(Full title of the plan)
Karim Mikhail
President and Chief Executive Officer
Amarin Corporation plc
c/o Amarin Pharma, Inc.
440 Route 22
Bridgewater, NJ 08807
(Name and address of agent for service)
Telephone: (908) 719-1315
(Telephone number, including area code, of agent for service)
Please send copies of all communications to:
Michael H. Bison, Esq.
Jacqueline Mercier, Esq.
Goodwin Procter LLP
100 Northern Avenue
Boston, MA 02210
Telephone: (617) 570-1000
Facsimile: (617) 523-1231
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
| Emerging growth company | ☐ | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
In May 2022, the Board of Directors of Amarin Corporation plc (the “Company”) approved, subject to shareholder approval, Amendment No. 1 to the Company’s 2020 Stock Incentive Plan (the “Plan”), which increased the aggregate number of Shares (as defined in the Plan) authorized for issuance under the Plan by 10,000,000 Shares (the “Plan Amendment”). At the Company’s 2022 Annual General Meeting held on June 27, 2022 (the “2022 AGM”), the Company’s shareholders approved the Plan Amendment. The contents of the Company’s Registration Statement on Form S-8 (File No. 333-240321) filed with the Securities and Exchange Commission (the “Commission”) on August 4, 2020, relating to the Plan, is incorporated by reference into this Registration Statement pursuant to General Instruction E to Form S-8. This Registration Statement registers, among other securities described below, (a) the 10,000,000 Shares reserved for issuance under the Plan pursuant to the Plan Amendment and (b) 4,416,888 Shares underlying awards that expired, were forfeited, surrendered, canceled or otherwise terminated in whole or in part, other than through exercise, under the Company’s 2011 Stock Incentive Plan (as amended, the “2011 Plan”) subsequent to July 13, 2020, which may be made available for grants under the Plan (pursuant to the Plan) at the discretion of the Remuneration Committee of the Amarin Board of Directors.
Part I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Item 1. Plan Information.
The documents containing the information specified in this Item 1 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act of 1933 (the “Securities Act”). In accordance with the rules and regulations of the Commission and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.
Item 2. Registrant Information and Employee Plan Annual Information.
The documents containing the information specified in this Item 2 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the Commission and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
Amarin Corporation plc (the “Company”) hereby incorporates by reference in this Registration Statement the following documents previously filed by the Company with the Commission:
| 1. | The Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as amended on May 2, 2022 (other than information furnished rather than filed); |
| 2. | The Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022, respectively; |
| 3. | The Company’s Current Reports on Form 8-K filed with the Commission on January 10, 2022, May 20, 2022, June 6, 2022 and June 30, 2022; and |
| 4. | The description of the ordinary shares contained in the “Description of Registrant’s Securities” filed as Exhibit 4.4 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. |
All documents that the Company subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act” ) prior to the filing of a post-effective amendment to this Registration Statement which indicates that all of the ordinary shares offered have been sold or which deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Under no circumstances will any information furnished under Items 2.02 or 7.01 of a Current Report on Form 8-K be deemed incorporated herein by reference, unless such Form 8-K expressly provides to the contrary.
Item 8. Exhibits.
| * | Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Dublin Ireland, on August 5, 2022.
| Amarin Corporation plc | ||
| By: | /s/ Karim Mikhail | |
| Karim Mikhail, President and Chief Executive Officer | ||
SIGNATURES AND POWER OF ATTORNEY
We, the undersigned officers and Directors of Amarin Corporation plc, hereby severally constitute and appoint Karim Mikhail, Tom Reilly, and Jason Marks, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign for us and in our names in the capacities indicated below any and all amendments (including post-effective amendments) to this registration statement on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date | ||
| /s/ Karim Mikhail |
Director, President and Chief Executive | August 5, 2022 | ||
| Karim Mikhail | Officer (Principal Executive Officer) | |||
| /s/ Tom Reilly |
Senior Vice President and Chief Financial Officer | August 5, 2022 | ||
| Tom Reilly | (Principal Financial and Account Officer) | |||
| /s/ Lars G. Ekman, M.D., Ph.D. |
Director | August 5, 2022 | ||
| Lars G. Ekman, M.D., Ph.D. | ||||
| /s/ Erin Enright |
Director | August 5, 2022 | ||
| Erin Enright | ||||
| /s/ Jan van Heek |
Director | August 5, 2022 | ||
| Jan van Heek | ||||
| /s/ Patrick J. O’Sullivan |
Director | August 5, 2022 | ||
| Patrick J. O’Sullivan | ||||
| /s/ Kristine Peterson |
Director | August 5, 2022 | ||
| Kristine Peterson | ||||
| /s/ Per Wold-Olsen |
Director | August 5, 2022 | ||
| Per Wold-Olsen | ||||
| /s/ Alfonso “Chito” Zulueta |
Director | August 5, 2022 | ||
| Alfonso “Chito” Zulueta | ||||